Nearly half of US rheumatologists expect Gazyva to meaningfully reshape SLE treatment pathways, while CAR T-cell therapy is ...
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease driven by both genetic susceptibility and environmental risk factors. Epigenetic processes, which lie at the intersection of ...
A research team of Professor Yoontae Lee and Jiho Park, a PhD candidate, from the Department of Life Sciences at Pohang University of Science and Technology (POSTECH) recently discovered that a ...
Please provide your email address to receive an email when new articles are posted on . “These findings suggest that IFN-I blocking agents may be particularly effective in treating skin manifestations ...
In a new study, researchers discovered a potential new gene biomarker, ELF1, a protein coding gene, that can be used to diagnose and evaluate people with systemic lupus erythematosus (SLE). The ...
The trial met its primary composite endpoint demonstrating significant clinical improvement with dapirolizumab pegol vs placebo in patients with moderate to severe SLE. Topline results were announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results